Levobunolol

Drug Status in USA : Approved
Drug Status in Canada : Approved

Indication : Why is this medication prescribed?

Indicated for lowering intraocular pressure in chronic open angle glaucoma and ocular hypertension.

Contraindication: What are the special precautions to be followed?

Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Bronchial asthma/severe chronic obstructive pulmonary disease, sinus bradycardia, second and third degree AV block, overt cardiac failure, cardiogenic shock. Hypersensitivity Pregnancy, lactation and paediatrics age group.

Other Precaution to be observed while taking this medication

In patients with non-allergic bronchospasm. Patients of diabetes mellitus who are concurrently receiving insulin or oral hypoglycaemic agents. Patients at risk of developing hypoglycaemia. Thyrotoxicosis. Cerebrovascular insufficiency.

What are possible side effects of this medication ?

Transient ocular burning and stinging, decrease in heart rate and blood pressure, urticaria pruritus, decreased corneal sensitivity. Iridocyclitis, headache, transient ataxia, dizziness and lethargy. Lethargy, decreased corneal sensitivity, tearing, visual disturbances, urticaria and pruritus.

Drug Category/Class

  • Sympatholytics
  • Adrenergic beta-Antagonists
  • Beta Blocking Agents
  • EENT Preparations
  • Ophthalmologicals
  • Sensory Organs
  • Antiglaucoma Preparations and Miotics
  • Beta blocking agents
Prescribed For lowering intraocular pressure (IOP) and may be used in patients with chronic open-angle glaucoma or ocular hypertension.
Weight :291.3853
Structure Levobunolol
Generic Drug Levobunolol prescribed For lowering intraocular pressure (IOP) and may be used in patients with chronic open-angle glaucoma or ocular hypertension.
Formula

C17H25NO3

Levobunolol has 2 Brands listed


Betagan (Eye) (5 ml)Biozine (15 mg)

Search Generic Drugs alphabetically